Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety, Tolerability and Immunogenicity of Adjuvanted Candidate Vaccines Against Pandemic Influenza A (H1N1)

NCT01111968 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT01111968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01111968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety, Tolerability and Immunogenicity of Adjuvanted Candidate Vaccines Against Pandemic Influenza A (H1N1)
Lead sponsor
Butantan Institute
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2010
Completion date
March 31, 2011
Enrollment
266 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza